Neuronetics, Inc. (STIM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuronetics, Inc. on November 12, 2024. The filing addresses a regulatory matter concerning the company's listing status on The Nasdaq Global Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding stock listing requirements.
Material Changes
The primary material event is the resolution of a prior non-compliance issue with Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").
- Previous Status: On October 4, 2024, the company received notice of non-compliance because its common stock failed to maintain a minimum bid price of $1.00 per share.
- Resolution: The company regained compliance by maintaining a closing bid price of $1.00 per share or more for 10 consecutive business days, a requirement met on November 11, 2024.
- Current Status: Nasdaq has notified the company that the matter is closed and the stock remains included on The Nasdaq Global Market.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of new risks or contingencies beyond the resolution of the bid price deficiency.
Investor Verification Checklist
- Confirm the current trading price of STIM to ensure it remains above the $1.00 threshold to avoid future delisting notices.
- Review the October 4, 2024 Form 8-K for details on the initial non-compliance notice.
- Monitor subsequent filings for any updates on the company's financial performance or operational strategy.